Clearside Bio

IPO

Clearside Bio is a biotech company in Hatteras, United States, founded in 2012. It has raised $20.0M across 2 rounds, most recently a $16.0M Series B in September 2014.

Clearside Biomedical

Employees
11–50
Founded
2012
Business Model
B2B
Total Funding
$20.0M
Last Round
$16.0M Series BSep 2014
Rounds
2
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 1 investor for this company. The full record is or through the API.

About

Clearside Biomedical, Inc. is an intellectual property holding, investment, and commercialization company with a portfolio of intellectual property covering its proprietary suprachoroidal space (SCS) ocular drug-delivery platform and microinjector technology. Following its emergence from Chapter 11 in 2026, the Company operates with a recapitalized balance sheet, free of legacy liabilities, and is focused on rehabilitating or otherwise utilizing and monetizing its retained intellectual property.

Summary

It lists 11–50 employees. It has raised $20.0M in total across 2 rounds, most recently a $16.0M Series B round in Sep 2014. Investors include Hatteras Venture Partners.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Data from Indexed.vcUpdated
Debt FinancingVenture RoundAug 2022
$65.0M

Sign up to see all 4 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Clearside Bio on Indexed.vc
<a href="https://indexed.vc/companies/clearside-bio"><img src="https://indexed.vc/api/badge/company/clearside-bio" alt="Clearside Bio on Indexed.vc" width="260" height="76" /></a>